Kaken Pharmaceutical Co., Ltd. (TYO:4521)

Kaken Pharmaceutical Revenue

In the fiscal year ending March 31, 2026, Kaken Pharmaceutical had annual revenue of 76.87B JPY, down -18.25%. Kaken Pharmaceutical had revenue of 19.25B in the quarter ending March 31, 2026, with 6.70% growth.

• Revenue: 76.87B
• Revenue Growth: -18.25%
• P/S Ratio: 1.96
• Revenue / Employee: 68.27M
• Employees: 1,126
• Market Cap: 150.72B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	76.87B	-17.16B	-18.25%
Mar 31, 2025	94.04B	21.99B	30.52%
Mar 31, 2024	72.04B	-940.00M	-1.29%
Mar 31, 2023	72.98B	-3.05B	-4.01%
Mar 31, 2022	76.03B	1.06B	1.41%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error